Marshall Wace, LLP Applied Genetic Technologies Corp Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $38,168 - $59,396	-20,411 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.01 - $4.12 $61,437 - $84,093	20,411 New	20,411 $61,000
Q1 2020 May 15, 2020	SELL	$2.36 - $9.86 $190,938 - $797,733	-80,906 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.69 - $4.92 $155,449 - $284,316	-57,788 Reduced 41.67%	80,906 $366,000
Q3 2019 Nov 14, 2019	BUY	$2.59 - $4.16 $359,217 - $576,967	138,694 New	138,694 $577,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.